B, D., RB, D., SE, K., S, J., G, B., U, d. F., . . . Beevers, G. (2002). Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet, 359(9311), 995-1004.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
B, Dahlöf, et al. "Cardiovascular Morbidity and Mortality in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): A Randomised Trial Against Atenolol."
Lancet 359, no. 9311 (2002): 995-1004.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
B, Dahlöf, et al. "Cardiovascular Morbidity and Mortality in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): A Randomised Trial Against Atenolol."
Lancet, vol. 359, no. 9311, 2002, pp. 995-1004.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.